{
  "id": "a3e2da692863bfce",
  "title": "Santhera Licenses AGAMREE\u00ae ( Vamorolone ) to Nxera Pharma in Japan , South Korea , Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties",
  "description": "20260108T083000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/08/tmt-newswire/globenewswire/santhera-licenses-agamree-vamorolone-to-nxera-pharma-in-japan-south-korea-australia-and-new-zealand-in-a-deal-valued-at-up-to-usd-205-million-plus-royalties/2255110",
  "published_at": "20260108T083000Z",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/08/tmt-newswire/globenewswire/santhera-licenses-agamree-vamorolone-to-nxera-pharma-in-japan-south-korea-australia-and-new-zealand-in-a-deal-valued-at-up-to-usd-205-million-plus-royalties/2255110",
    "url_mobile": "https://www.manilatimes.net/2026/01/08/tmt-newswire/globenewswire/santhera-licenses-agamree-vamorolone-to-nxera-pharma-in-japan-south-korea-australia-and-new-zealand-in-a-deal-valued-at-up-to-usd-205-million-plus-royalties/2255110/amp",
    "title": "Santhera Licenses AGAMREE\u00ae ( Vamorolone ) to Nxera Pharma in Japan , South Korea , Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties",
    "seendate": "20260108T083000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/08/892020.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}